URGN Earnings

URGN reported its earnings on 2026-03-02, showcasing a revenue of 37.84M against an estimate of 35.55M, resulting in a 6.43% surprise. The EPS was -0.54, surpassing the expected -0.66 by 18.18%. The stock experienced a -12.35% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following URGN's earnings announcement on 2026-03-02, the stock price moved by -12.35% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, URGN's stock price tends to shift by an average of -0.41% in the 10 days leading up to earnings and -2.87% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate URGN's annual revenue to reach 43.66M, while the EPS is projected at -0.51. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between URGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, URGN's stock price typically moves by -0.41% in the 10 days before its earnings and -2.87% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.51 and revenue of 43.66M.

The earnings call summary indicates strong product development and market strategy, with ZUSDURI outperforming JELMYTO and expanding into community practices. Despite increased expenses and net loss, the optimistic guidance for ZUSDURI and strategic transition plans to UGN-103 suggest positive future prospects. The Q&A section reinforces confidence in ZUSDURI's growth, despite management's cautious responses. The absence of negative financial surprises and steady product adoption supports a positive sentiment, likely leading to a stock price increase of 2% to 8%.